Literature DB >> 10801052

Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

R B Pour1, S Stöckler-Ipsiroglu, D H Hunneman, M Gahr, G C Korenke, W Pabst, F Hanefeld, A Peters.   

Abstract

Lymphocytopenia and depression of natural killer cells have been observed in patients with adrenoleukodystrophy (ALD) treated with glycerol trioleate and glycerol trierucate ('Lorenzo's oil'). To investigate possible alterations of cellular immunoreactivity, we measured lymphocyte proliferation in response to mitogens (PHA, Con A, PWM, OKT3) in 27 patients on treatment and in 14 patients without treatment. In patients on treatment, lymphocyte proliferation in response to the mitogens PHA and Con A was significantly higher than in patients without treatment. Lymphocyte proliferation in patients without treatment was comparable to that of normal control lymphocytes. Additionally, we found increased concentrations of erucic acid, C22:1, in lymphocytes from patients with treatment. The enhanced proliferation of lymphocytes in response to mitogens is an indication of increased reactivity of cellular immunity to unspecific immunological stimuli. Long-term side-effects on cellular immunoreactivity have to be considered in ALD patients treated with Lorenzo's oil.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801052     DOI: 10.1023/a:1005657530372

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.

Authors:  P Sedlmayr; B Plecko; E Paschke; W Zenz; H Ramschak; H Toplak; T C Wascher; M Wilders-Truschnig; S Stöckler
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Lorenzo's oil and lymphocytopenia.

Authors:  C J Unkrig; R Schröder; R E Scharf
Journal:  N Engl J Med       Date:  1994-02-24       Impact factor: 91.245

3.  Giant platelets in erucic acid therapy for adrenoleukodystrophy.

Authors:  S Stöckler; B Molzer; B Plecko; W Zenz; W Muntean; U Söling; D H Hunneman; C Korenke; F Hanefeld
Journal:  Lancet       Date:  1993-05-29       Impact factor: 79.321

4.  Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation.

Authors:  T A Chatila; D H Schwartz; R Miller; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1987-08

5.  Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

Authors:  S Stöckler; C Opper; A Greinacher; D H Hunneman; G C Korenke; C J Unkrig; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

6.  Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.

Authors:  S Zierz; R Schröder; C J Unkrig
Journal:  Clin Investig       Date:  1993-10

7.  Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters.

Authors:  G C Korenke; D H Hunneman; J Kohler; S Stöckler; K Landmark; F Hanefeld
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

8.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

9.  Dietary erucic acid therapy for X-linked adrenoleukodystrophy.

Authors:  W B Rizzo; R T Leshner; A Odone; A L Dammann; D A Craft; M E Jensen; S S Jennings; S Davis; R Jaitly; J A Sgro
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

10.  Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  G Uziel; E Bertini; P Bardelli; M Rimoldi; M Gambetti
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

View more
  1 in total

1.  Effects of erucic acid supplemented feeding on chronic doxorubucin toxicity in rats.

Authors:  Evin Bozcali; Oner Süzer; Hatice Nilüfer Gürsoy; Pinar Atukeren; Koray M Gümüstas
Journal:  Int J Clin Exp Med       Date:  2009-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.